Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-23Clinical Trial Update: Trigeminal Nerve Stimulation of the Treatment of Epilepsy [NA]
A clinical trial investigating trigeminal nerve stimulation for treatment-refractory epilepsy; the study is currently active but not recruit…
-
EMA approval · 2025-10-22EMA Authorised: Zonisamide Viatris (previously Zonisamide Mylan) (zonisamide) — Viatris Limited
EMA authorised zonisamide for epilepsy under the Viatris Limited marketing authorisation. The product was previously marketed as Zonisamide …
-
FDA approval · 2025-10-16FDA Approved: ZTALMY — Supplemental Application (Immedica Pharma US Inc)
FDA approves a supplemental application for ZTALMY (ganaxolone) submitted by Immedica Pharma US Inc.
-
FDA approval · 2025-10-15FDA Approved: LACOSAMIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for lacosamide, a generic anticonvulsant, under the ANDA framework. The notice…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Assessing Comorbidities in Epilepsy Using Eye Movement Recordings
A completed clinical trial update examining comorbidities in epilepsy using eye movement recordings, with a focus on childhood absence epile…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Effect of Vagal Nerve Stimulation on Gastric Motor Functions [NA]
A Mayo Clinic study is currently recruiting to evaluate the effect of vagus nerve stimulation on gastric motor function in people with depre…
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Testing a Novel Dry Electrode Headset for Electroencephalography Telehealth [NA]
A VA-sponsored clinical trial is evaluating a novel dry electrode EEG headset for telehealth in epilepsy and is currently enrolling by invit…
-
CLINICAL_TRIALS research · 2025-10-14Clinical Trial Update: Optimizing Brain Stimulation Parameters [NA]
This Mayo Clinic trial update describes efforts to optimize brain stimulation parameters for epilepsy and seizures, and it is currently recr…
-
FDA label_change · 2025-10-10FDA Approved: LAMICTAL ODT — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Lamictal ODT (lamotrigine) from GlaxoSmithKline, likely updating labeling to reflect the orally …
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants With Childhood Epilepsy [Phase 2]
A Phase 2 study evaluating the efficacy and safety of Perampanel as adjunctive therapy in pediatric epilepsy with partial-onset seizures; re…
-
CLINICAL_TRIALS research · 2025-10-09Clinical Trial Update: Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet [Phase 1, Phase 2]
This update describes an ongoing Phase 1/Phase 2 trial at Johns Hopkins University evaluating cardiovascular risk factors in adults with epi…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: High-field MR Imaging in Migraine, Visual Snow and Epilepsy
A University of Zurich-sponsored clinical trial is recruiting participants to study high-field MRI imaging in migraine, epilepsy, and Visual…
-
FDA approval · 2025-10-07FDA Approved: TOPIRAMATE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental ANDA for Topiramate from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Evaluating the Efficacy of a Mobile Epilepsy Education Application [NA]
This completed clinical trial from McGill University Health Centre evaluated the efficacy of a mobile epilepsy education application. The st…
-
FDA approval · 2025-10-07FDA Approved: LAMOTRIGINE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' generic lamotrigine as an original application, authorizing the first generic version of lamotri…
-
CLINICAL_TRIALS other · 2025-10-07Clinical Trial Update: Wearable Epileptic Seizure Prediction and Alert Glasses Based on Neuromorphic Computing [NA]
This clinical trial is testing wearable glasses that predict epileptic seizures using neuromorphic computing, sponsored by the Oman Ministry…
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: A Survey of Midazolam in People With Status Epilepticus
A clinical trial survey evaluating the use of midazolam in people with status epilepticus; the study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-03Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures [Phase 2]
A Phase 2 study evaluating the efficacy, safety, and pharmacokinetics of lacosamide in neonates with repeated electroencephalographic neonat…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Risk Prevention Program and Therapeutic Patient Education Program of Patients With Uncontrolled Epilepsy [NA]
This document reports a clinical trial update for a risk prevention program and therapeutic patient education program in patients with uncon…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Pharmacological Modulation of Brain Oscillations in Memory Processing [EARLY_Phase 1]
An early-phase 1 trial at UT Southwestern Medical Center is evaluating a pharmacological approach to modulate brain oscillations to support …
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Prevalence of ADHD in Children With Epilepsy
This clinical trial will assess how common ADHD is among children with epilepsy. It is currently not yet recruiting.
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: REACH: RWE Retrospective Study to Evaluate Cenobamate Impact on Health Care Resource Utilization
A real-world retrospective study (REACH) sponsored by Angelini Pharma is recruiting to evaluate cenobamate's impact on health care resource …
-
CLINICAL_TRIALS withdrawal · 2025-10-02Clinical Trial Update: Brain-Shift Monitoring Using 3D Scanning
A clinical trial evaluating brain-shift monitoring using 3D scanning has been terminated.
-
FDA approval · 2025-10-01FDA Approved: PREGABALIN — Supplemental Application (Creekwood Pharmaceuticals LLC)
The FDA approved a supplemental application for pregabalin from Creekwood Pharmaceuticals LLC under ANDA213423.
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging
An ongoing sponsor-initiated study is evaluating metabolism, connectivity, and ultra-high-field mesoscopic imaging to uncover mechanisms of …